Asian Spectator

Fluxergy Announces Improved Clinical Performance of Its CE-IVD COVID-19 PCR Test

  • Written by Fluxergy, Inc.

IRVINE, CA. - News Aktuell - 11 May 2021 - Fluxergy, Inc.[1], a U.S. medical diagnostic point-of-care platform company with a detection technology solution capable of multiplexity and multimodality, is further announcing improved clinical performance of its CE-IVD COVID-19 RT-PCR test. The CE marking for its one-hour COVID-19 Test Kit allows healthcare professionals to use its in vitro diagnostics (IVD) assay for the detection of SARS-CoV-2. Fluxergy's innovative testing platform is approved for IVD use in the European Union market and any other markets that accept CE marking as valid regulatory approval.

Fluxergy Announces Improved Clinical Performance of Its CE-IVD COVID-19 PCR Test

The Fluxergy Diagnostic System: The Fluxergy Analyzer, which conducts the testing; the Fluxergy Card, a single-use test cartridge and its reagents; and the FluxergyWorks software, to manage the test data. The Fluxergy Test Kit COVID-19 is only available for purchase in the European Union market and any other markets that accept the CE-marking as valid regulatory approval. COURTESY: FLUXERGY, INC.

 

The simple workflow of the Fluxergy platform allows for a NP swab sample collected in a VTM or UTM vial and mixed with the Fluxergy Reaction Mixture within three minutes. This can then be immediately loaded onto the Fluxergy Card and inserted into the Fluxergy Analyzer for qualitative real-time PCR results within one hour. The platform is ideal for rapid testing applications such as emergency testing and delivery ward testing, as well as community reopening testing where expedited turnaround times are critical.

 

In the most recent clinical performance comparison study conducted by Fluxergy using ninety-five U.S. clinical specimens collected from November 2020 to March 2021, the COVID-19 Fluxergy Test Kit was 100% concordant with Cepheid's Xpert Xpress SARS-CoV-2 (the gold standard for COVID-19 RT-PCR at the Point-of-Care, approved for CE-IVD and other regions).

 

References

  1. ^ Fluxergy, Inc. (www.fluxergy.com)

Authors: Fluxergy, Inc.

Read more https://www.media-outreach.com/news/2021-05-11/77596/fluxergy-announces-improved-clinical-performance-of-its-ce-ivd-covid-19-pcr-test

Magazine

Di bawah standar WHO: 3 alasan anggaran kesehatan harus ditingkatkan di era Prabowo

Prabowo-Gibran yang pencalonannya sebagai Presiden dan Wakil Presiden memantik kontroversi telah mulai bekerja sejak 20 Oktober 2024.Untuk mengawal pemerintahan mereka, kami menerbitkan edisi khusus #...

Teknologi baru sel surya tandem pecahkan rekor dunia dalam efisiensi energi

Thanun Vongsuravanich / ShutterstockPanel surya yang dipasang di atap rumah dan lahan pembangkit energi skala besar telah menjadi pemandangan biasa di berbagai belahan dunia. Tenaga surya kini menjadi...

Seperti ‘trick or treat’, film horor adalah ciri khas Halloween−tapi mengapa harus berdarah-darah?

Banyak sekali film horor di tahun 2024, dan banyak di antaranya yang mempertontonkan adegan berdarah secara terang-terangan. Tahun ini, sejumlah film ‘berdarah’ memasuki pasaran, seperti I...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion